High Prevalence of Antibodies Against COVID-19 Within the General Population: Evidence from Nairobi and Kilifi

Simple item page
dc.contributor.authorKEMRI-Wellcome Trust Research Programme
dc.date.accessioned2024-04-04T13:08:13Z
dc.date.available2024-04-04T13:08:13Z
dc.date.issued2022-06-30
dc.description.abstractBy May 2022, 69% of individuals residing within the Kilifi Health and Demographic System (HDSS) and 91% residing within the Nairobi Urban HDSS had evidence of an immune response to COVID-19 resulting from natural infection and/or vaccination, i.e., anti-spike IgG antibodies.The majority of HDSS residents with anti-spike IgG antibodies appear to have developed them as a result of natural infection, as only 11% - 27% of study participants reported receiving one or more doses of COVID-19 vaccine by May 2022.en_US
dc.description.sponsorshipThe Bill & Melinda Gates Foundationen_US
dc.identifier.citationAPHRC and KEMRIen_US
dc.identifier.urihttp://knowhub.aphrc.org/handle/123456789/793
dc.language.isoen_USen_US
dc.subjectCOVID-19en_US
dc.subjectHealth and Demographic Surveillance Systemen_US
dc.subjectHDSSen_US
dc.subjectanti-spike IgG antibodiesen_US
dc.subjectKilifi HDSSen_US
dc.subjectNairobi Urban HDSSen_US
dc.titleHigh Prevalence of Antibodies Against COVID-19 Within the General Population: Evidence from Nairobi and Kilifien_US
dc.typeWorking Paperen_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
High-prevalence-of-antibodies-against-COVID-19-within-the-general-population-Evidence-from-Nairobi-and-Kilifi.pdf
Size:
641.88 KB
Format:
Adobe Portable Document Format
Description:
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

2022